Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it plans to report second quarter 2008 financial results on Thursday, July 31, 2008, following the close of market. Ligand’s President and CEO, John L. Higgins, Vice President of Finance and CFO, John P. Sharp and Vice President of Discovery Research, Dr. Martin Meglasson will host the conference call.
| What: |
Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates. |
|
| When: | Thursday, July 31, 2008 | |
| Time: | 1:30 p.m. Pacific time (4:30 p.m. Eastern time) | |
| Webcast: |
Conference call and replay accessible at www.ligand.com. |
|
| Conference Call: | (877) 356-5578, ID # 55282270 (U.S.) | |
| (706) 679-0565, ID # 55282270 (outside the U.S) | ||
| Replay: | (800) 642-1687, ID # 55282270 (U.S.) | |
| (706) 645-9291, ID # 55282270 (outside the U.S.) | ||
|
Replay of conference call will be available from July 31, 2008 to August 31, 2008. |
||
About Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of thrombocytopenia, hepatitis C, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology.
Ligand Pharmaceuticals Incorporated
John L. Higgins, President and
CEO or
Erika Luib, Investor Relations
858-550-7896
or
Lippert/Heilshorn
& Associates
Don Markley
310-691-7100
dmarkley@lhai.com
